| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.24B | +17.6% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.04B | -3.9% |
| Gross margin | 30.4% | Net margin 16.8% |
| Revenue Q/Q | -10.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.17B | 69.6% |
| R&D | ¥0.01B | 3.2% |
| SG&A | ¥0.02B | 8.1% |
| Tax & other | ¥0.01B | 3.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华绿生物 ・ 博亚精工 ・ 万辰集团 ・ 立高食品 ・ 商络电子 ・ 达瑞电子 ・ 深圳瑞捷 ・ 东箭科技 ・ 华利集团 ・ 祥源新材 ・ 中红医疗 ・ 苏文电能
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies